BIOTECHNOLOGY VALUE FUND L P - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for Verastem, Inc. (VSTM)

Reporting Manager
BVF PARTNERS L P/IL
Symbol
VSTM
Shares outstanding
47.1M shares
Disclosed Ownership
4.71M shares
Ownership
9.99%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:26 PM
Date of event
Dec 31, 2024

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 6% 2.79M 0 2.79M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 6% 2.79M 0 2.79M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3.8% 1.7M 0 1.7M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3.8% 1.7M 0 1.7M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 183K 0 183K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 183K 0 183K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.5% 4.49M 0 4.49M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.99% 4.71M 0 4.71M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.99% 4.71M 0 4.71M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.99% 4.71M 0 4.71M /s/ Mark N. Lampert Mark N. Lampert